Psoriatic Arthritis

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
Philip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, Iain McInnes

Annals of the Rheumatic Diseases Feb 2021, 80 (2) 185-193; DOI: 10.1136/annrheumdis-2019-216835
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1532-1543; DOI: 10.1136/annrheumdis-2020-217092
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
Philip Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel Kremer, Jeffrey Greenberg, Wendi Malley, Alina Onofrei, Keith S Kanik, Daniela Graham, Cunshan Wang, Carol Connell, Hernan Valdez, Manfred Hauben, Eric Hung, Ann Madsen, Thomas V Jones, Jeffrey R Curtis

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1400-1413; DOI: 10.1136/annrheumdis-2019-216761
DAPSA versus cDAPSA: Do we need to use CRP?
Rafaela Silva Guimarães Gonçalves, Lays Miranda de Almeida Martins, Henrique de Ataide Mariz, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte

Annals of the Rheumatic Diseases Nov 2020, 79 (11) e142; DOI: 10.1136/annrheumdis-2019-215960
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need to use CRP?’ by Gonçalves et al
Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique Baeten, Laura C Coates

Annals of the Rheumatic Diseases Nov 2020, 79 (11) e143; DOI: 10.1136/annrheumdis-2019-215990
Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Jian Tian, Chao Cheng, Fangjie Zhang

Annals of the Rheumatic Diseases Sep 2020, 79 (9) e112; DOI: 10.1136/annrheumdis-2019-215745
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
Vinod Chandran, Richard J Cook, Dafna D Gladman

Annals of the Rheumatic Diseases Sep 2020, 79 (9) e113; DOI: 10.1136/annrheumdis-2019-215762
Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
Emma Dures, Julie Taylor, Sasha Shepperd, Sandeep Mukherjee, Joanna Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1031-1036; DOI: 10.1136/annrheumdis-2020-217301
Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritis
Alen Zabotti, Garifallia Sakellariou, Ilaria Tinazzi, Luca Idolazzi, Alberto Batticciotto, Marco Canzoni, Greta Carrara, Orazio De Lucia, Fabiana Figus, Nicolò Girolimetto, Pierluigi Macchioni, Rebecca McConnell, Niccolò Possemato, Annamaria Iagnocco

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1037-1043; DOI: 10.1136/annrheumdis-2020-217191
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Gerd R Burmester, Juan D Canete, Nemanja S Damjanov, Tue Wenzel Kragstrup, Tore K Kvien, Robert B M Landewé, Rik Jozef Urbain Lories, Helena Marzo-Ortega, Denis Poddubnyy, Santiago Andres Rodrigues Manica, Georg Schett, Douglas J Veale, Filip E Van den Bosch, Désirée van der Heijde, Josef S Smolen

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 700-712; DOI: 10.1136/annrheumdis-2020-217159

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages